Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS works closely with employees in the post-Reitz settlement process
2013-05-20

20 May 2013

In the light of an article in IOL News on 18 and 19 May 2013 and in Sunday Independent and Sunday Tribune on 19 May 2013 in which it is alleged that the University of the Free State (UFS) has failed to honour its commitment to the five Reitz employees we are pleased to report on the ongoing process and progress made with respect to their employment.

The university remained consistently true to the settlement agreement and High Court order of 2011 and cannot apologise for complying with the law. It was therefore impossible for us to talk to our colleagues directly until last week when we had a breakthrough meeting, which was cleared by the Human Rights Commission (HRC), and matters were resolved.

The UFS continues to work closely and now directly with the five employees to ensure that their rights as employees remain the highest priority in the post-settlement process.
 
All but one of the conditions of the Reitz settlement (own business) has already been met; however, we are in the process of providing training and support for the establishment of an independent business led by the employees.

After some delays, and frustration on all sides, we have found the right training provider for them and are satisfied that the process remains on track. The business office (furnished) has been allocated at the South Campus in Bloemfontein.

Already in late 2012 the Chair of the HRC expressed his satisfaction with the commitments made by the university to the process. By 30 June 2013 this outstanding commitment to establish an independent company with trained employees would also have been met in full.

Beyond the settlement agreement, the UFS has also committed to providing free education and training to the children of the employees so that their next generation of families emerge as strong, independent, well-trained and productive members of society. The child of one of the colleagues is in fact finishing Grade 12 this year and we are in discussion about possible studies at the UFS. This is our pledge and commitment as a university.

This final step in the post-Reitz settlement is being led by Dr Choice Makhetha, Vice-Rector of the University of the Free State.

 

Issued by: Lacea Loader
Director Strategic Communication
Tel: +27 (0) 51 401 2584 / +27 (0) 83 645 2454
E-mail: news@ufs.ac.za
Fax: +27 (0) 51 444 6393
Web: www.ufs.ac.za

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept